TARS TARSUS PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: not announced yet
What 10 analyst firms say about TARSUS PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
12 rated views · 13 analyst/firm records · 10 firms
Radar score
Recent analyst activity · last 90 days
Our tracked history has 10 reports on TARS from 9 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Guggenheim raised its target from $89.00 (set 21 Jul 2026) to $97.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Glen Santangelo | Buy | 16 Sep 2026 | 110.00 USD |
| Barclays | Jenna Davidner | Buy | 16 Sep 2026 | 110.00 USD |
| Goldman Sachs | Andrea Newkirk | Buy | 24 Sep 2026 | 116.00 USD |
| Guggenheim | Brad Canino | Buy | 21 Jul 2026 | 89.00 USD |
| Guggenheim | Eddie Hickman | Buy | 13 Jul 2026 | 89.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 4 Nov 2026 | 106.00 USD |
| Jefferies | Anthony Petrone | Buy | 8 Sep 2026 | 105.00 USD |
| Jefferies | Dennis Ding | Buy | 4 Sep 2026 | 105.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 31 Jul 2026 | Conflicting reports · excluded |
| Oppenheimer | Francois Brisebois | Buy | 12 Aug 2026 | 100.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Lachlan Hanbury-Brown | Buy | 12 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 13 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:46 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.